Clay Siegall- Working to Better Drug Treatments

The founder and CEO of Seattle Genetics, Dr. Clay Siegall has been making an impact in the business world for quite some time. He has spent much of his time focusing on fighting disease through the production of drugs that fight sickness in a unique way. Clay Siegall recently sat down with inspirery to share insight into his success and what drives him each day.


Clay Siegall was inspired to began business out of an interesting situation. Growing up he always had an interest in medicine and technology. In particular he was always curious as to how nature would intervene to stop disease. This interest was increased when a family member diagnosed nearly died as a result of the chemotherapy treatment they were receiving. Siegall began researching possible solutions for the problem and this ultimately led to the business he does today.


Siegall’s company, Seattle Genetics makes money from selling thier own, proprietary drugs. His first drug ADCetris has done very well. The drug itself was the first FDA-approved antibody drug conjugate. Furthermore the company also makes quite an earning from partnerships as well as licensing certain technologies that the company has developed themselves. The company had done quite well but the success did not come over night. It took Seattle Genetics nearly ten years before becoming profitable. Siegall credits his hard work ethic as the ultimate reason for success.


Co-founder of Seattle Genetics Dr. Clay Siegall has worked hard to reach his current success. He holds two degrees including a B.S. in zoology from The University of Maryland and a Ph.D from George Washington University. Under his leadership, Seattle Genetics has built a tremendous group of cancer therapies. Before and During the time he worked with Seattle Genetics he has partnered with a number of well known groups including National Cancer Institute, Bristol-Myers Squibb Pharmaceutical Research Institute and the National Institutes of Health. He is also an accomplished author with more than seventy publications.

Clay Siegall & How He’s Changing Cancer Research


When it comes to cancer research, there are numerous organization on the market today. Just about everyone has been affected by cancer in some form either directly or indirectly. This deadly disease can manifest within the body as well as in a number of vital organs. As of today, cancer research has come along way, but the fight isn’t over, rather it’s just getting started. Have you ever heard of a guy named Clay Siegall? If you haven’t then just know that this guy is in a class of his own and he has a huge list of accomplishments to back up all claims.

Clay Siegall is the Founder, CEO, and president of one of the leading cancer research organizations in the world. Seattle Genetics is it’s name and saving lives is it’s game. This Bothell, Washington based company has risen to the top of it’s class as it specializes in the development and commercialization of cancer breakthrough therapies. Clay Siegall is the captain of this ship and with his strong leadership, Seattle Genetics has become the go to organization of choice when it comes to producing the very best in cancer fighting treatments. Over the past five years, the company’s stock has tripled thanks to it’s powerful and effective medications. It’s flagship drug ADCETRIS, has become one of the most widely used cancer medications in the world today thanks to Clay Siegall. Siegall has enter the powerful medication into strategic licensing deals with some of the most prominent names in the world such as GlaxoSmithKline, Genentech, and Pfizer.

Having such a broad educational background, Clay Siegall has become the industry’s leading man. With a Ph.D in Genetics and a (BS) in Zoology, this brilliant minded man has more than enough knowledge, expertise, and capabilities. Siegall has also helped raise over $1 Billion dollars in private/public funding. With Clay Siegall steering this ship, the hopes of eradicating cancer is inevitable.